United Therapeutics Corp (UTHR) Tops Q2 EPS Views
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $549.90 +1.02%
EPS Growth %: +12.6%
Financial Fact:
Interest expense: -500K
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +12.6%
Financial Fact:
Interest expense: -500K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
United Therapeutics Corp (NASDAQ: UTHR) reported Q2 EPS of $1.49, $0.96 better than the analyst estimate of $0.53. Revenue for the quarter came in at $183.75 million versus the consensus estimate of $180.84 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Increasing unusual option volume: UTHR DOMO IHI XIFR ALKS AM CTSH GDS DFTX
- Worthington Industries (WOR) Misses Q4 EPS by 9c
- Cerebras Q1 EPS miss sends shares down 9% after-hours
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
